These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 23467774)
1. Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report. De Nardo P; Bellagamba R; Corpolongo A; Gentilotti E; Taglietti F; Rosati S; Galeazzi M; Sebastiani GD; Quinti I; Nicastri E Clin Vaccine Immunol; 2013 May; 20(5):761-4. PubMed ID: 23467774 [TBL] [Abstract][Full Text] [Related]
2. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Kobie JJ; Zheng B; Bryk P; Barnes M; Ritchlin CT; Tabechian DA; Anandarajah AP; Looney RJ; Thiele RG; Anolik JH; Coca A; Wei C; Rosenberg AF; Feng C; Treanor JJ; Lee FE; Sanz I Arthritis Res Ther; 2011; 13(6):R209. PubMed ID: 22177419 [TBL] [Abstract][Full Text] [Related]
3. Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis. Kubota T; Nii T; Nanki T; Kohsaka H; Harigai M; Komano Y; Sugihara T; Nonomura Y; Hirose W; Nagasaka K; Sakurai T; Miyasaka N Mod Rheumatol; 2007; 17(6):531-3. PubMed ID: 18084712 [No Abstract] [Full Text] [Related]
4. Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: three case studies from Saudi Arabia. Almoallim H; Jali I; Wali G Joint Bone Spine; 2013 Jul; 80(4):426-8. PubMed ID: 23453475 [TBL] [Abstract][Full Text] [Related]
5. Etanercept treatment of rheumatoid arthritis in the "real world". Smith MD Ann Rheum Dis; 2003 Jan; 62(1):95-6; author reply 96. PubMed ID: 12480688 [No Abstract] [Full Text] [Related]
6. Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis. Duffy TN; Genta M; Moll S; Martin PY; Gabay C Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S106. PubMed ID: 16859610 [No Abstract] [Full Text] [Related]
8. Anti-TNF agents for rheumatoid arthritis. Seymour HE; Worsley A; Smith JM; Thomas SH Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065 [TBL] [Abstract][Full Text] [Related]
9. Creutzfeldt-Jakob disease in a patient treated by etanercept for rheumatoid arthritis (RA): just a coincidence? Soubrier M; Haïk S; Hauw JJ; Corvol JC; Lyon-Caen O; Dougados M Joint Bone Spine; 2010 Mar; 77(2):174-5. PubMed ID: 20097590 [TBL] [Abstract][Full Text] [Related]
10. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Williams VL; Cohen PR Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984 [TBL] [Abstract][Full Text] [Related]
11. Paradoxical psoriatic arthritis in a patient with rheumatoid arthritis treated by TNFα blocker. Villani AP; Weiler L; Jullien D; Chapurlat R; Confavreux C Joint Bone Spine; 2014 Oct; 81(5):455-6. PubMed ID: 24561024 [No Abstract] [Full Text] [Related]
12. A case of cellulitis causing tissue defect during etanercept therapy. Deniz D; Ebru U; Ajda B; Gulsum TM; Semih T; Aytul C Rheumatol Int; 2012 Jan; 32(1):241-4. PubMed ID: 20020139 [TBL] [Abstract][Full Text] [Related]
13. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents. Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750 [TBL] [Abstract][Full Text] [Related]
14. Septic shock and community-acquired pneumonia associated with etanercept therapy. Nuñez-Cornejo C; Borrás-Blasco J; Gracia-Perez A; Rosique-Robles JD; Lopez-Camps V; Casterã E; Abad FJ Int J Clin Pharmacol Ther; 2008 Apr; 46(4):193-7. PubMed ID: 18397693 [TBL] [Abstract][Full Text] [Related]
19. Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review. De Angelis F; Di Rocco A; Minotti C; Valesini G; Cartoni C; Riminucci M; Conti F; Finolezzi E; Armiento D; Grammatico S; Massaro L; Fama A; Colafigli G; Viccarone C; Foà R; Martelli M Leuk Res; 2012 Sep; 36(9):e199-201. PubMed ID: 22749557 [No Abstract] [Full Text] [Related]
20. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Cepeda EJ; Williams FM; Ishimori ML; Weisman MH; Reveille JD Ann Rheum Dis; 2008 May; 67(5):710-2. PubMed ID: 18079191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]